Eurofins Scientific SE (EPA:ERF)

Market Cap	12.31B +8.4%
Revenue (ttm)	7.39B +3.4%
Net Income	469.90M +22.5%
EPS	2.56 +28.9%
Shares Out	173.60M
PE Ratio	27.72
Forward PE	16.12
Dividend	0.72 (0.98%)
Ex-Dividend Date	Apr 28, 2026

Volume	105,981
Open	70.90
Previous Close	70.92
Day's Range	70.72 - 71.54
52-Week Range	54.86 - 74.78
Beta	0.85
Analysts	Hold
Price Target	72.24 (+1.46%)
Earnings Date	Jul 23, 2026

About Eurofins Scientific SE

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. It provides services, such as agroscience, including biological assessment, consumer and human, environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, including sustainability, audit, certification, quality inspection, QA-QC programme, and food and dietary supplement labelling services; biopharma, and clinical diagnostics. The company also offers consumer product tes...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1987
• Employees: 65,000
• Stock Exchange: Euronext Paris
• Ticker Symbol: ERF

Financial Performance

In 2025, Eurofins Scientific SE's revenue was 7.30 billion, an increase of 4.96% compared to the previous year's 6.95 billion. Earnings were 416.10 million, an increase of 16.78%.

Analyst Summary

According to 14 analysts, the average rating for ERF stock is "Hold." The 12-month stock price target is €72.24, which is an increase of 1.46% from the latest price.

Price Target

€72.24

(1.46% upside)

Analyst Consensus: Hold

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 11, 2026

Data Sources Report a data error